The Role of the JAK2 GGCC Haplotype and the TET2 Gene in Familial Myeloproliferative Neoplasms

Haematologica - Italy
doi 10.3324/haematol.2010.034488
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)

Related search

JAK2 Haplotype Is a Major Risk Factor for the Development of Myeloproliferative Neoplasms

Nature Genetics
Genetics
2009English

The JAK2 46/1 (GGCC ) MPN-Predisposing Haplotype: A Risky Haplotype, After All

American Journal of Hematology
Hematology
2018English

Frequency of Heterozygous TET2 Deletions in Myeloproliferative Neoplasms

Cancer Management and Research
Oncology
2010English

Advances in Understanding the Pathogenesis of Familial Myeloproliferative Neoplasms

British Journal of Haematology
Hematology
2017English

Frequency and Clinical Correlates of JAK2 46/1 (GGCC) Haplotype in Primary Myelofibrosis

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2010English

JAK2 and MPL Mutations in Myeloproliferative Neoplasms: Discovery and Science

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2008English

Role of Mesenchymal Stromal Cells and Their Extracellular Vesicles microRNAs in JAK2 Myeloproliferative Neoplasms

English

JAK2 Exon 14 Deletion in Patients With Chronic Myeloproliferative Neoplasms

PLoS ONE
Multidisciplinary
2010English

JAK2, CALR, and MPL Mutation Spectrum in Japanese Patients With Myeloproliferative Neoplasms

Haematologica
Hematology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy